23 results
8-K
EX-10.1
ORGO
Organogenesis Holdings Inc - Ordinary Shares
9 Aug 21
Organogenesis Holdings Inc. Reports Second Quarter and First Half 2021 Financial Results
4:09pm
.
Insurance
No Casualty
[Reserved]
OFAC
Anti-Corruption Laws
Affected Financial Institution
SECTION 5 CONDITIONS PRECEDENT
Conditions …
[Reserved]
Additional Collateral, Etc.
Licensee Consent
Use of Proceeds
Designated Senior Indebtedness
Anti-Corruption Laws; Sanctions
Further
424B4
ORGO
Organogenesis Holdings Inc - Ordinary Shares
16 Nov 20
Prospectus supplement with pricing info
4:57pm
corruption to some degree and in certain circumstances, strict compliance with anti-bribery laws may conflict with local customs and practices
8-K
EX-1.1
k327f1sl4 hpcqygwj
22 Nov 19
Organogenesis Holdings Inc. Announces Proposed Public Offering of Class A Common Stock
4:15pm
8-K
EX-10.1
syq8fakeo6a 3j
14 Mar 19
Organogenesis Holdings Inc. Announces New $100 Million Credit Agreement with Silicon Valley Bank and MidCap Financial
4:23pm
POS AM
ooooc4ywsz25pj
11 Feb 19
Prospectus update (post-effective amendment)
8:50am
424B3
boh4dwq4s
4 Feb 19
Prospectus supplement
8:11am
S-3/A
988rdyw
10 Jan 19
Shelf registration (amended)
12:00am
S-3
rj7 hr021
24 Dec 18
Shelf registration
12:00am
8-K
EX-10.24
r6a41jjhn2sd
11 Dec 18
Report of Independent Registered Public Accounting Firm
5:14pm
424B3
edt4au yptultgefiy6
30 Nov 18
Prospectus supplement
1:40pm